VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CTHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CTHRCharles & Colvard, Ltd.
$0.10$304032
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTHRBalance Sheet

Charles & Colvard, Ltd. (CTHR) Balance Sheet

28Y historyFree accessUpdated daily

The company's financial position appears increasingly fragile, with total assets declining to $29.1 million and accumulated retained earnings reaching a deficit of $64.2 million as of 2025Q3.

CTHR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'24Jun'23Jun'22Jun'21Jun'20Jun'19Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets9.04M18.82M24.58M35.86M35.76M23.91M27.87M20.15M20.67M24.38M24.03M28.04M30.75M20.05M18.18M12.16M21.58M34.81M52.54M59.32M45.49M40.07M38.43M34.61M28.69M30M36.1M44.5M1.2M
Cash & Short-Term Investments1.26M4.14M10.45M15.67M21.3M13.99M12.47M4.59M7.43M11.11M5.25M2.57M12.37M6.7M7.74M7.41M5.59M7.05M13.76M21M12.87M11.56M13.28M10.24M3.83M13.2M32M44M1.2M
Cash Only1.26M4.14M10.45M15.67M21.3M13.99M12.47M4.59M7.43M11.11M5.25M2.57M11.86M6.7M7.74M7.41M5.59M7.05M13.76M21M12.87M11.56M13.28M10.24M3.83M13.2M32M44M1.2M
Short-Term Investments000000000000505.07K0000000000000000
Accounts Receivable707.43K1.09M630.09K2.47M1.91M670.72K1.96M3.38M2.79M2.23M4.46M10.24M8.14M6.08M3.8M1.1M5.97M9.84M14.71M11.53M7.02M3.71M2.21M2.82M1.49M1.3M600K200K0
Days Sales Outstanding22.818.27.6820.9317.798.3922.2145.634.9726.4463.52131.26132.55138.34109.2848.21148.06129.07131.9196.67107.1678.5248.889.3742.4238.5854.75730-
Inventory5.95M7.51M7.48M11.02M11.45M7.44M11.91M11.21M9.77M10.12M13.4M13.07M8.44M6.85M6.31M3.47M8.29M16.19M22.7M25.61M24.7M24.07M22.37M21.34M23.07M14.8M3.1M300K0
Days Inventory Outstanding176163.45108.23176.13200.83128.15250.52264.45174.8179.75271.62326.86309.4384.01477.01364.72541.14776.64767.54646.421.05K1.34K1.24K1.52K1.6K947.72419.07--
Other Current Assets1.13M6.08M5.66M5.51M144.63K913.2K820.06K303.69K075001.2M1.21M00129.42K1.23M980.67K583.32K600.66K455.77K235.18K250.6K0301.27K700K400K00
Total Non-Current Assets11.02M22.16M24.31M33.34M29.16M25M23.28M21.08M19.83M17.45M23.21M34.28M29.22M33.6M32.73M38.37M36.44M28.34M13.46M4.21M5.14M6.38M7.52M632.85K921.98K6.8M4.1M400K0
Property, Plant & Equipment3.37M4.32M4.67M4.69M4.83M1.58M1.03M1.24M1.39M1.32M1.66M1.72M1.75M1.42M377.35K218.42K412.23K597.35K651.13K496.34K524.64K453.84K449.95K342.28K552.27K6.3M3.8M200K0
Fixed Asset Turnover4.08x5.08x6.41x9.19x8.13x18.44x31.42x21.76x20.97x23.35x15.41x16.58x12.83x11.28x33.62x38.06x35.72x46.57x62.52x87.73x45.59x37.99x36.70x33.61x23.17x1.95x1.05x0.50x-
Goodwill00000000000000000000000000000
Intangible Assets383.41K370.19K305.7K265.73K209.66K170.15K97.37K8.6K8.81K5.56K172.9K325.87K346.73K248.81K252.54K260.55K279.31K358.33K288.17K298.52K348.44K274.89K272.29K290.57K369.71K500K300K100K0
Long-Term Investments00000000000003.76M1.02M00000000000000
Other Non-Current Assets7.27M17.47M19.33M22.54M17.77M23.24M22.15M19.83M18.43M16.13M21.38M29.4M24.38M28.17M31.08M37.89M34.81M26.85M11.83M263.71K0000000100K0
Total Assets29.11M40.98M48.88M69.21M64.92M48.9M51.15M41.23M40.51M41.83M47.24M62.32M59.97M53.65M50.91M50.53M58.03M63.15M66M63.54M50.64M46.45M45.95M35.24M29.61M36.8M40.2M44.9M1.2M
Asset Turnover0.49x0.54x0.61x0.62x0.60x0.60x0.63x0.66x0.72x0.74x0.54x0.46x0.37x0.30x0.25x0.16x0.25x0.44x0.62x0.69x0.47x0.37x0.36x0.33x0.43x0.33x0.10x0.00x0.08x
Asset Growth %-115.74%-16.17%-29.37%6.6%32.75%-4.38%24.05%1.79%-3.17%-11.44%-24.2%3.92%11.79%5.38%0.75%-12.92%-8.11%-4.32%3.88%25.48%9.02%1.08%30.38%19.03%-19.54%-8.46%-10.47%3641.67%-
Total Current Liabilities9.48M14.13M7.06M6.8M5.62M6.49M4.7M5.45M4.61M4.02M4.83M4.5M2.89M1.85M1.16M596.39K2.83M4.33M6.73M5.57M3.38M2.32M2.2M1.16M2.75M3.3M2.2M800K0
Accounts Payable6.07M8.27M4.79M4.4M2.77M3.75M3.28M4.47M3.98M3.06M3.31M3.67M2.11M1.06M542.08K265.44K1.63M3.35M4.47M2.93M2.23M1.32M902.96K559.85K2M2.9M1.9M800K0
Days Payables Outstanding211.49180.1569.2970.3248.6664.5368.98105.3771.1554.3967.1591.7677.4259.484127.9106.45160.71151.1374.0194.9273.1350.0439.77138.49185.7256.85--
Short-Term Debt922.92K2.3M880.13K856.57K566.08K815.49K00000000000000000000000
Deferred Revenue (Current)301.16K0566.9K452.87K774.89K794.74K0131.39K00000000171.18K0000448.27K183.37K129.8K00000
Other Current Liabilities2.31M2.65M-434.17K99.58K872.65K415.58K1.35M197.23K130.68K183K000000881.24K721.76K1.52M1.59M590.63K0723.47K202.01K753.06K400K300K00
Current Ratio0.95x1.33x3.48x5.27x6.36x3.69x5.93x3.70x4.49x6.07x4.98x6.23x10.65x10.81x15.61x20.39x7.63x8.04x7.81x10.65x13.47x17.25x17.49x29.73x10.44x9.09x16.41x55.63x-
Quick Ratio0.33x0.80x2.42x3.65x4.32x2.54x3.40x1.64x2.37x3.55x2.20x3.33x7.73x7.12x10.20x14.58x4.70x4.30x4.44x6.05x6.16x6.89x7.31x11.40x2.04x4.61x15.00x55.25x-
Cash Conversion Cycle-12.691.546.62126.74169.9672203.75204.68138.61151.8267.99366.36364.53462.87545.29385.03582.75745748.32669.081.06K1.34K1.24K1.57K1.51K800.59216.97--
Total Non-Current Liabilities534.92K1.2M2.05M2.85M3.61M982.95K729.58K925.12K1.03M1.08M1.18M395.44K408.13K741.64K937.41K1.06M3.15M911.61K4.47M2.93M2.23M1.77M1.09M689.65K2M2.9M1.9M100K0
Long-Term Debt534.92K0000772K00000000000000000000000
Capital Lease Obligations2.19M1.2M2.05M2.85M3.6M203K00000000000000000000000
Deferred Tax Liabilities00000000000000000000000000000
Other Non-Current Liabilities00009.88K7.95K729.58K925.12K1.03M1.08M1.18M395.44K408.13K00000000000000100K0
Total Liabilities10.02M15.33M9.11M9.65M9.23M7.47M5.43M6.37M5.64M5.1M6M4.9M3.3M2.6M2.1M1.66M5.98M5.24M6.73M5.57M3.38M2.32M2.2M1.16M2.75M3.3M2.2M900K0
Total Debt1.46M4.41M2.93M3.7M4.17M2.41M00000000000000000000000
Net Debt200.74K269K-7.52M-11.96M-17.14M-11.58M-12.47M-4.59M-7.43M-11.11M-5.25M-2.57M-11.86M-6.7M-7.74M-7.41M-5.59M-7.05M-13.76M-21M-12.87M-11.56M-13.28M-10.24M-3.83M-13.2M-32M-44M-1.2M
Debt / Equity0.08x0.17x0.07x0.06x0.07x0.06x-----------------------
Debt / EBITDA-0.13x--1.10x0.69x------------------------
Net Debt / EBITDA-0.02x---3.57x-2.82x--4.54x------14.08x-4.19x-5.61x---13.40x-1.43x-2.24x-3.98x-5.12x-4.96x-9.75x-----
Interest Coverage-85.54x-253.06x--615.21x-7144.49x1030.74x-1124.85x-2266.45x-921.91x-10037.98x-750.37x185.77x1138.77x438.64x--------0.73x-----
Total Equity19.09M25.65M39.77M59.56M55.69M41.44M45.72M34.86M34.87M36.73M41.24M57.43M56.68M51.05M48.81M48.88M52.05M57.91M59.28M57.97M47.26M44.12M43.75M34.08M26.86M33.5M38M44M1.2M
Equity Growth %-149.56%-35.51%-33.22%6.95%34.4%-9.37%31.16%-0.03%-5.08%-10.92%-28.19%1.32%11.02%4.6%-0.14%-6.09%-10.13%-2.3%2.26%22.66%7.1%0.85%28.39%26.87%-19.82%-11.84%-13.64%3566.67%-
Book Value per Share6.128.4513.0919.0218.4214.4720.6816.3616.6618.0020.3228.852.842.592.512.612.853.213.183.062.622.482.442.072.863.634.1611.780.21
Total Shareholders' Equity19.09M25.65M39.77M59.56M55.69M41.44M45.72M34.86M34.87M36.73M41.24M57.43M56.68M51.05M48.81M48.88M52.05M57.91M59.28M57.97M47.26M44.12M43.75M34.08M26.86M33.5M38M44M1.2M
Common Stock67.23M67.23M57.24M57.24M56.06M54.34M54.34M54.24M54.24M54.24M54.24M53.95M53.32M52.83M53.11M52.91M52.91M52.91M52.49M57.79M56.5M54.33M54.97M55.18M49.23M48.8M000
Retained Earnings-64.19M-57.55M-43.18M-23.6M-25.98M-38.79M-33.11M-34.11M-33.66M-31.43M-25.29M-6.46M-5.1M-9.55M-11.12M-10.44M-7.04M-892.69K975.18K-5.13M-11M-12.62M-13.66M-23.07M-24.29M-17.2M-12.1M-5.3M-400K
Treasury Stock0-489.98K-489.98K-38.16K0000000000000000000000000
Accumulated OCI0000000-3.45M-3.02M00-2.47M-1.88M-1.35M-1.56M-1.47M-1.2M881-457-2.85K-770.55K-721.71K-581.32K-473.16K-390.87K-900K-200K00
Minority Interest00000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and existential obsolescence

Rapid Erosion of Asset Base

As reported in recent SEC filings, CTHR's total assets have plummeted from $66.9 million in 2023Q2 to $29.1 million by 2025Q3, reflecting a consistent and aggressive contraction of the company's balance sheet that mirrors its ongoing struggle to maintain market relevance in the synthetic gemstone sector.

The steady decline in total assets suggests that the company is consuming its capital base to fund persistent operating losses rather than reinvesting for growth. This trajectory implies that the firm's ability to support its current operational footprint is diminishing, warranting significant concern regarding its long-term viability.

Liquidity Buffer Nearing Critical Threshold

Based on the company's latest quarterly data, cash reserves have dwindled to just $1.3 million as of 2025Q3, down from $12.0 million in 2023Q2, which indicates a rapidly narrowing liquidity buffer that leaves the firm with minimal protection against further operational shocks or unforeseen market volatility.

The current ratio has compressed to 0.95, signaling that current liabilities now exceed current assets, which may indicate an inability to meet short-term obligations without external financing. Investors should monitor this trend closely, as the current cash burn rate suggests the company may soon face a liquidity crisis.

Accumulated Deficits Undermining Equity Quality

According to financial statements, retained earnings have deteriorated to a staggering -$64.2 million as of 2025Q3, a trend that highlights the persistent destruction of shareholder value and the erosion of equity quality resulting from years of sustained operating losses and ineffective capital allocation strategies.

The consistent growth of the accumulated deficit suggests that the company has failed to achieve a profitable business model, effectively consuming its equity base. This pattern implies that future growth initiatives may require dilutive equity raises, further pressuring the value of existing shareholder stakes.

Inventory Valuation and Obsolescence Risk

As indicated by the company's balance sheet, the reliance on inventory in a market where lab-grown diamond prices are falling suggests that the carrying value of assets may be overstated, potentially necessitating future non-cash write-downs that would further impair the company's already fragile financial position.

The lack of deferred revenue in recent periods, compared to historical levels, may indicate a decline in forward-looking customer commitments or a shift in sales recognition patterns. This distortion warrants investigation, as it may mask the true extent of the company's declining demand and inventory turnover challenges.

CTHR — Frequently Asked Questions

Quick answers to the most common questions about buying CTHR stock.

What are the total assets of Charles & Colvard, Ltd. (CTHR)?

As of 2024, Charles & Colvard, Ltd. (CTHR) had total assets of $41.0M including $18.8M in current assets.

How much debt does Charles & Colvard, Ltd. (CTHR) have?

Charles & Colvard, Ltd. (CTHR) carries total debt of $4.4M, offset by $4.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. (CTHR) has total shareholders' equity (book value) of $25.6M ($8.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Charles & Colvard, Ltd.'s current ratio and liquidity?

Charles & Colvard, Ltd. (CTHR) reported a current ratio of 1.33x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.